|
14 Jan 2011 |
Health Canada Requests Additional Information to Support Application for Approval of Prochymal
|
|
12 Jan 2011 |
VistaGen Therapeutics and NuPotential Receive NIH Grant to Develop Safer Approaches for Producing Patient-Specific Induced Pluripotent Stem Cells
|
|
12 Jan 2011 |
Fibrocell Science, Inc. Announces FDA Accepts for Review Complete Response Submission for Azficel-T
|
|
10 Jan 2011 |
Geron Announces Publication Demonstrating Activity of Imetelstat Against Cancer Stem Cells From Pediatric Neural Tumors
|
|
10 Jan 2011 |
Enzon to Begin Phase 1 Study of Novel Androgen Receptor mRNA Antagonist in Castration-Resistant Prostate Cancer
|
|
10 Jan 2011 |
Excaliard Announces Positive Results From Three Phase 2 Clinical Trials for EXC 001, Showing Significant Improvement in Both Hypertrophic and Fine Line Scarring
|
|
10 Jan 2011 |
Sangamo BioSciences Announces Completion of Enrollment of Phase 2b Clinical Trial in Diabetic Neuropathy
|
|
10 Jan 2011 |
Interim Results From Mesoblast's Phase 2 Heart Failure Trial Shows 'Off-The-Shelf' Proprietary Adult Stem Cell Product Revascor Reduces Cardiac Events, Mortality, and Hospitalization
|
|
10 Jan 2011 |
Bioheart Reports Positive Results for Adipose Derived Stem Cells in Critical Limb Ischemia
|
